About 279,000 results
Open links in new tab
  1. ASH VTE Guidelines: Prophylaxis for Medical Patients

    This one-page snapshot provides a high-level summary of the guidelines on the types of interventions that should be used to prevent VTE in hospitalized and non-hospitalized medical patients.

  2. We discuss four major topics: VTE risk stratification, in-hospital VTE prophylactic options, consideration for post-discharge prophylaxis and thromboembolic prevention in COVID-19 patients.

  3. For patients on the minimal spine pathway OR preliminarily nonoperative with only upright imaging pending, VTE prophylaxis may be initiated. Patients with an ICP monitor or external ventricular drain …

  4. Sep 16, 2021 · Medical patients who warrant DVT prophylaxis should have prophylaxis initiated as soon as they are determined to be at risk and should receive prophylaxis throughout their hospitalization …

  5. Critically ill patients are at significant risk for venous thromboembolism (VTE) due to inactivity, immobilization, vascular injury, and/or hypercoagulable states. Appropriate VTE prophylaxis varies …

  6. UW Medicine Recommended Practices based on Antithrombotic Therapy and Prevention of Thrombosis, 9th Edition, American College of Chest Physicians Evidence Based Clinical Practice …

  7. Thromboprophylaxis in hospitalized and nonhospitalized medical …

    Sep 13, 2023 · The purpose of the 2018 VTE guideline on VTE prophylaxis for medical patients who were hospitalized and those who were not hospitalized was to provide evidence-based …

  8. Antithrombotic Therapy for VTE Disease - CHEST

    Aug 2, 2021 · In patients with VTE diagnosed in the absence of transient provocation (unprovoked VTE or provoked by persistent risk factor), we recommend offering extended-phase anticoagulation with a …

  9. Oct 15, 2024 · All patients receiving prophylaxis should undergo duplex screening of the lower extremities on hospital day 3 and every 7 days thereafter while in the hospital.

  10. Evidence-based recommendations for the prevention of venous thromboembolism (VTE) in patients with cancer, including those who are hospitalized, undergoing surgery, ambulatory, and/or have a central …